Try it
Radiology · Nuclear medicine: peptide receptor radionuclide therapy
Sample itemA patient with a progressive metastatic midgut neuroendocrine tumour shows intense uptake on a gallium-68 DOTATATE PET scan. Which therapy exploits this finding?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
D. Lutetium-177 DOTATATE
Strong somatostatin receptor expression on imaging predicts uptake of the same peptide labelled with a therapeutic beta emitter. Lutetium-177 DOTATATE delivers radiation locally to receptor-positive tumour cells.
Option by option
A. External beam whole-brain irradiation
Whole-brain radiation is not directed at a receptor-positive abdominal tumour.
B. Strontium-89 chloride
Strontium-89 is used to palliate bone pain from metastases.
C. Radioiodine-131 sodium iodide
Radioiodine treats thyroid tissue that traps iodide.
D. Lutetium-177 DOTATATE (correct)
Correct. A therapeutic analogue of the imaging peptide is the logical choice.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Radiology questions
- NeuroimagingWhat is the first investigation of choice in suspected acute subarachnoid haemorrhage?
- Cardiac imagingA 'boot-shaped' heart (coeur en sabot) on a chest radiograph is typical of:
- Musculoskeletal imagingA 'bamboo spine' on a plain radiograph is characteristic of:
- Paediatric radiologyThe 'double bubble' sign on an abdominal radiograph of a newborn suggests: